Close Menu

NEW YORK (GenomeWeb) – VolitionRx announced today that it has signed a global sales and distribution agreement with Active Motif for a set of research-use-only kits, based on VolitionRx's Nucleosomics technology.

VolitionRx's RUO kits are based on the same Nu.Q immunoassay technology as the firm's cancer screening panels, and may be useful for exploring clinical questions beyond cancer biomarkers, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Jun
04
Sponsored by
NanoCellect

This webinar will discuss a study that used CRISPR/Cas9 to engineer mice harboring risk variants associated with glaucoma in order to assess their functional relevance.